German health insurers prioritise medical technology
This article was originally published in Clinica
If Germany's healthcare costs are to be kept under control, the current trend of introducing innovative and generally expensive medical technology into the reimbursement catalogue of the German statutory health insurance funds must be addressed. This is just one of the issues dealt with in a position paper on the future of the health service, launched last week by the leading groups of the statutory health insurance funds (GKV).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.